TD Cowen maintains Hold on Brown-Forman, raises target to $29

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

TD Cowen analyst Seamus Cassidy maintained a Hold rating on Brown-Forman (NYSE: BF) and raised the price target to $29 from $25.

powered bylight_fuzz_icon
44040518

*this image is generated using AI for illustrative purposes only.

TD Cowen analyst Seamus Cassidy has maintained a Hold rating on Brown-Forman (NYSE: BF) while raising the price target for the stock. The new target is set at $29, an increase from the previous estimate of $25.

Rating and Price Action

The brokerage firm adjusted its valuation outlook for the spirits company, signaling a revised expectation for the stock's performance potential. The decision to maintain a Hold rating suggests that the stock is expected to perform in line with the broader market or sector averages in the near term.

Metric Value
Rating Hold
Previous Price Target $25
New Price Target $29
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What factors drove TD Cowen to raise the price target while maintaining a Hold rating?

How might Brown-Forman's upcoming earnings report influence future analyst ratings?

What are the key risks or opportunities for Brown-Forman in the current spirits market?

like17
dislike

Barclays downgrades Brown-Forman to Equal-Weight, keeps $27 target

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Barclays analyst Lauren Lieberman downgraded Brown-Forman from Overweight to Equal-Weight while maintaining the price target at $27.

powered bylight_fuzz_icon
43953097

*this image is generated using AI for illustrative purposes only.

Barclays analyst Lauren Lieberman has downgraded Brown-Forman from Overweight to Equal-Weight, maintaining the price target at $27. The rating adjustment reflects a revised outlook on the stock while the price objective remains unchanged.

Rating and Price Target

The downgrade moves Brown-Forman from a higher-conviction Overweight rating to a more neutral Equal-Weight stance. Despite the rating change, the price target is held steady at $27.

Metric Previous New
Rating Overweight Equal-Weight
Price Target $27 $27
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors led to the downgrade despite the unchanged price target?

How might this rating change impact investor sentiment toward Brown-Forman in the short term?

What are the key risks or challenges Brown-Forman faces that could affect its future performance?

like16
dislike